glycolaldehyde has been researched along with Cardiovascular Diseases in 3 studies
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Haesen, S | 2 |
| Cöl, Ü | 1 |
| Schurgers, W | 1 |
| Evens, L | 2 |
| Verboven, M | 2 |
| Driesen, RB | 2 |
| Bronckaers, A | 1 |
| Lambrichts, I | 2 |
| Deluyker, D | 2 |
| Bito, V | 2 |
| Kuster, D | 1 |
| Beliën, H | 1 |
| van der Velden, J | 1 |
| Domingo-Espín, J | 1 |
| Nilsson, O | 1 |
| Bernfur, K | 1 |
| Del Giudice, R | 1 |
| Lagerstedt, JO | 1 |
3 other studies available for glycolaldehyde and Cardiovascular Diseases
| Article | Year |
|---|---|
Glycolaldehyde-modified proteins cause adverse functional and structural aortic remodeling leading to cardiac pressure overload.
Topics: Acetaldehyde; Acetylcholine; Animals; Aorta; Blood Pressure; Cardiovascular Diseases; Collagen; Cycl | 2020 |
Glycolaldehyde-Derived High-Molecular-Weight Advanced Glycation End-Products Induce Cardiac Dysfunction through Structural and Functional Remodeling of Cardiomyocytes.
Topics: Acetaldehyde; Animals; Aorta; Cardiovascular Diseases; Diastole; Glycation End Products, Advanced; H | 2020 |
Site-specific glycations of apolipoprotein A-I lead to differentiated functional effects on lipid-binding and on glucose metabolism.
Topics: Acetaldehyde; Animals; Apolipoprotein A-I; Blood Glucose; Cardiovascular Diseases; Cell Line; Choles | 2018 |